PMEF
AVNS icon

Point72 Middle East FZE’s Avanos Medical AVNS Stock Holding History

Point72 Middle East FZE’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,776
Closed -$107K – 135
2023
Q4 		$107K Buy
+4,776
New +$98.6K ﹤0.01% 1176

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Point72 Middle East FZE's AVNS Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Avanos Medical (AVNS) in Q1 2024, closing a stake of 4,776 shares — an estimated $107K sold.

Point72 Middle East FZE first reported a position in AVNS in Q4 2023 and held it in 1 quarter. The position peaked at $107K in Q4 2023. 260 funds tracked by Wall St. Rank hold AVNS as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Avanos Medical position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 4,776 Avanos Medical shares in Q1 2024, an estimated $107K.
  • Point72 Middle East FZE first reported a position in Avanos Medical in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Avanos Medical position peaked at $107K in Q4 2023.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.